375 related articles for article (PubMed ID: 12355109)
21. [Possibilities and limits of oral diabetes therapy].
Bruneder H
Wien Med Wochenschr; 1985 Apr; 135(6-7):147-51. PubMed ID: 3890376
[No Abstract] [Full Text] [Related]
22. Pharmacologic management of diabetes mellitus.
Mozersky RP
J Am Osteopath Assoc; 1999 Dec; 99(12 Suppl):S15-9. PubMed ID: 10659525
[TBL] [Abstract][Full Text] [Related]
23. [News on diabetes and public health perspectives].
Solignac M
Presse Med; 2002 Nov; 31(39 Pt 1):1860-3. PubMed ID: 12496717
[No Abstract] [Full Text] [Related]
24. Targeted glycemic control in type 2 diabetes.
Skyler JS
J Fla Med Assoc; 1998 Aug; 85(2):7-15. PubMed ID: 9782713
[No Abstract] [Full Text] [Related]
25. Oral pharmacologic management of type 2 diabetes.
Riddle MC
Am Fam Physician; 1999 Dec; 60(9):2613-20. PubMed ID: 10605995
[TBL] [Abstract][Full Text] [Related]
26. Insulin initiation in Type 2 diabetes.
Page S
Diabet Med; 2005 Sep; 22 Suppl 4():2-5. PubMed ID: 16109011
[No Abstract] [Full Text] [Related]
27. Pharmacological management of type 2 diabetes mellitus: an update.
El-Kaissi S; Sherbeeni S
Curr Diabetes Rev; 2011 Nov; 7(6):392-405. PubMed ID: 21846326
[TBL] [Abstract][Full Text] [Related]
28. [Modern methods of correction of systemic inflammation and insulin resistance by patients with coronary heart disease and diabetes mellitus type 2].
Rasin MS; Shaenko ZA
Lik Sprava; 2014; (3-4):60-5. PubMed ID: 25286600
[TBL] [Abstract][Full Text] [Related]
29. Oral antihyperglycemic therapy for type 2 diabetes: scientific review.
Inzucchi SE
JAMA; 2002 Jan; 287(3):360-72. PubMed ID: 11790216
[TBL] [Abstract][Full Text] [Related]
30. Oral combination therapy in primary care.
Kalra S; Gupta Y
J Pak Med Assoc; 2015 May; 65(5):574-5. PubMed ID: 26028398
[TBL] [Abstract][Full Text] [Related]
31. Combination oral agent and insulin therapy for type 2 diabetes mellitus.
Passaro MD; Ratner RE
Curr Diab Rep; 2001 Oct; 1(2):106-11. PubMed ID: 12643105
[TBL] [Abstract][Full Text] [Related]
32. New agents available for the treatment of diabetes.
Miller EC
Home Care Provid; 1996; 1(6):312-4. PubMed ID: 9188302
[No Abstract] [Full Text] [Related]
33. Pharmacotherapy of type 2 diabetes mellitus.
Rendell MS; Kirchain WR
Ann Pharmacother; 2000; 34(7-8):878-95. PubMed ID: 10928401
[TBL] [Abstract][Full Text] [Related]
34. Oral combination therapy for type 2 diabetes.
Charpentier G
Diabetes Metab Res Rev; 2002; 18 Suppl 3():S70-6. PubMed ID: 12324989
[TBL] [Abstract][Full Text] [Related]
35. Is there evidence that oral hypoglycemic agents reduce cardiovascular morbidity/mortality? Yes.
Bianchi C; Miccoli R; Daniele G; Penno G; Del Prato S
Diabetes Care; 2009 Nov; 32 Suppl 2(Suppl 2):S342-8. PubMed ID: 19875578
[No Abstract] [Full Text] [Related]
36. [Insulin monotherapy in patients with diabetes mellitus type 2 developing secondary resistance to sulfanilamide preparations].
Gendeleka GF
Lik Sprava; 2000 Mar; (2):72-4. PubMed ID: 10862482
[TBL] [Abstract][Full Text] [Related]
37. A miracle of salamization: positive divided by two equals negative.
Iwamoto Y
Diabet Med; 1997 Nov; 14(11):994. PubMed ID: 9400931
[No Abstract] [Full Text] [Related]
38. Oral agents in managing diabetes mellitus in children and adolescents.
Jacobson-Dickman E; Levitsky L
Pediatr Clin North Am; 2005 Dec; 52(6):1689-703. PubMed ID: 16301089
[TBL] [Abstract][Full Text] [Related]
39. Impact of glucose-lowering drugs on cardiovascular disease in type 2 diabetes.
Ferrannini E; DeFronzo RA
Eur Heart J; 2015 Sep; 36(34):2288-96. PubMed ID: 26063450
[TBL] [Abstract][Full Text] [Related]
40. Progression to insulin for patients with diabetes mellitus on dual oral antidiabetic therapy using the US Department of Defense Database.
Rascati K; Richards K; Lopez D; Cheng LI; Wilson J
Diabetes Obes Metab; 2013 Oct; 15(10):901-5. PubMed ID: 23531154
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
